Fosun International Ltd
- SEC CIK
- 0001447884
- Latest filing
- Aug 12, 2026
The latest 13F from Fosun International Ltd covers Q2 2026 (filed Aug 12, 2026): 73 long positions worth $446.2M. The top 10 holdings make up 80.3% of the portfolio, and the largest is Lanvin Group Holdings Ltd (LANV) at 29.6%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 15
- Est. +$48.5M
- Added
- 11
- Est. +$8.43M
- Reduced
- 17
- Est. −$35.8M
- Sold out
- 8
- Est. −$9.66M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
- State Street SPDR Portfolio S&P 500 ETF78464A854+$12.5MNew
- Invesco Nasdaq 100 ETF46138G649+$8.77MNew
- iShares Core MSCI Europe ETF46434V738+$8.12MNew
- iShares Semiconductor ETF464287523+$4.31MNew
- Vanguard S&P 500 ETF922908363+$4.16MNew
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- State Street SPDR Portfolio S&P 500 ETF78464A854+2.80 pp0.0% → 2.8%
- Invesco Nasdaq 100 ETF46138G649+1.96 pp0.0% → 2.0%
- iShares Core MSCI Europe ETF46434V738+1.82 pp0.0% → 1.8%
- iShares Semiconductor ETF464287523+0.96 pp0.0% → 1.0%
- Vanguard S&P 500 ETF922908363+0.93 pp0.0% → 0.9%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $446.2M
- +$47.7M (+12.0%) vs. prior quarter
- Positions
- 73
- +7 vs. prior quarter
- Top 10 concentration
- 80.3%
- Top 10 as share of value
- Turnover
- 10.8%
- Q2 2026, one quarter
- Average holding period
- 11.0 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $1.95B (Q3 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | 73 | $446.2M | LANVBFLYCHA | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 66 | $398.6M | LANVCHABFLY | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 11, 2026 | 54 | $429.5M | LANVCHABFLY | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 46 | $267.4M | LANVBFLYDBX ETF Tr | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 54 | $317.5M | LANVBFLYJ P Morgan Exchange Traded F | vs. Q1 2025 | SEC |
| Q1 2025 | May 14, 2025 | 48 | $355.0M | LANVNATRBFLY | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 47 | $319.6M | LANVNATRBFLY | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 52 | $303.7M | LANVNATRBFLY | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 8, 2024 | 46 | $296.3M | LANVNATRAMRX | vs. Q1 2024 | SEC |
| Q1 2024 | May 14, 2024 | 45 | $321.0M | LANVAMRXNATR | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 7, 2024 | 44 | $490.7M | LANVAMRXNATR | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 8, 2023 | 70 | $622.9M | LANVAMRXNATR | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 14, 2023 | 60 | $713.4M | LANVAMRXNATR | vs. Q1 2023 | SEC |
| Q1 2023 | Apr 28, 2023 | 63 | $1.06B | LANVVRAYMomo Inc | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 10, 2023 | 69 | $1.14B | LANVVRAYAMRX | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 69 | $547.2M | BNTXWEIBO CorpBFLY | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 10, 2022 | 64 | $721.8M | BNTXWEIBO CorpAMRX | vs. Q1 2022 | SEC |
| Q1 2022 | May 11, 2022 | 212 | $1.16B | BNTXAMRXWEIBO Corp | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 10, 2022 | 235 | $1.75B | BNTXNew Frontier Health CorpAMRX | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 12, 2021 | 224 | $1.95B | BNTXVRAYAMRX | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 12, 2021 | 203 | $1.68B | BNTXBFLYVRAY | vs. Q1 2021 | SEC |
| Q1 2021 | May 11, 2021 | 182 | $1.27B | BFLYAMRXNew Frontier Health Corp | – | SEC |
13D and 13G filings
Companies where Fosun International Ltd reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
1 company, largest stake first.
Latest filings
24 filings on file made by Fosun International Ltd or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| CHAChagee Holdings Ltd. | Aug 12, 20266:04 AM ET | 13G/A | 4.70%5.85M shares | −1.50 ppfrom 6.20%Below 5% | Jun 30, 2026 | SEC |
| CHAChagee Holdings Ltd. | Feb 12, 20266:01 AM ET | 13G/A | 6.20%7.45M shares | 0.00 ppfrom 6.20% | Dec 31, 2025 | SEC |
| CHAChagee Holdings Ltd. | Aug 14, 20256:12 AM ET | 13G | 6.20%7.45M shares | New | Jun 30, 2025 | SEC |
| LANVLanvin Group Holdings Ltd | Jul 1, 20254:35 PM ET | 13D/A | 71.92%90.3M shares | – | Jun 27, 2025 | SEC |
| LANVLanvin Group Holdings Ltd | Aug 6, 2024 | 13D/AOld format | – | – | – | SEC |
| LANVLanvin Group Holdings Ltd | Jun 17, 2024 | 13D/AOld format | – | – | – | SEC |
| AMRXAmneal Pharmaceuticals, Inc. | Apr 24, 2024 | 13G/AOld format | – | – | – | SEC |
| LANVLanvin Group Holdings Ltd | Apr 9, 2024 | 13D/AOld format | – | – | – | SEC |
| VRAYViewRay, Inc. | Feb 7, 2024 | 13G/AOld format | – | – | – | SEC |
| JGAurora Mobile Ltd | Feb 7, 2024 | 13G/AOld format | – | – | – | SEC |
| LANVLanvin Group Holdings Ltd | Feb 7, 2024 | 13D/AOld format | – | – | – | SEC |
| LANVLanvin Group Holdings Ltd | Dec 18, 2023 | 13D/AOld format | – | – | – | SEC |
| AMRXAmneal Pharmaceuticals, Inc. | Dec 12, 2023 | 13G/AOld format | – | – | – | SEC |
| VRAYViewRay, Inc. | Feb 3, 2023 | 13G/AOld format | – | – | – | SEC |
| JGAurora Mobile Ltd | Feb 3, 2023 | 13G/AOld format | – | – | – | SEC |
| LANVLanvin Group Holdings Ltd | Dec 23, 2022 | 13DOld format | – | New | – | SEC |
| JGAurora Mobile Ltd | Jan 21, 2022 | 13G/AOld format | – | – | – | SEC |
| Fang Holdings Ltd | Jan 21, 2022 | 13G/AOld format | – | – | – | SEC |
| VRAYViewRay, Inc. | Nov 10, 2021 | 13G/AOld format | – | – | – | SEC |
| JGAurora Mobile Ltd | Feb 1, 2021 | 13G/AOld format | – | – | – | SEC |